Skip to main content

Anthony Vecchione

By Anthony Vecchione | 01:53 pm | October 15, 2025
Verily's platform will be used to create biomedical data pipelines and develop novel AI/ML models across key therapeutic areas.
By Anthony Vecchione | 01:43 pm | October 15, 2025
Clarity uses video and audio to examine facial expressions and identify intimidating gestures and aggressive language.
By Anthony Vecchione | 09:51 am | October 14, 2025
The company, which changed its name from RIIG to Hootl in May, will use the funds for product development, regulatory preparedness and market growth.
By Anthony Vecchione | 11:16 am | October 13, 2025
Data from the study revealed that chronic exposure to cortisol disrupts neuronal network activity and damages long-term potentiation, simulating stress-related cognitive decline.
By Anthony Vecchione | 01:20 pm | October 10, 2025
The two companies will develop affordable peptide therapies aimed at extending women’s lifespan.
By Anthony Vecchione | 12:43 pm | October 10, 2025
The funds will be used to expand operations and attract new partners.
By Anthony Vecchione | 12:34 pm | October 10, 2025
The company received an additional equity investment from OrbiMed.
By Anthony Vecchione | 11:41 am | October 09, 2025
Sanofi will implement BenchSci's Ascend across its global research organization.
By Anthony Vecchione | 01:10 pm | October 08, 2025
An American Hospital Association webinar revealed that healthcare leaders consider AI integral to their revenue cycle management operation.
By Anthony Vecchione | 01:26 pm | October 07, 2025
OneStep's fall risk assessment and prevention capabilities will be merged with DarioHealth's chronic condition management platform.